Rozlytrek (entrectinib)

pCPA File Number: 21461
Negotiation Status:
Concluded with an LOI
Indication(s):
ROS1-positive Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche Limited
CDA-AMC Project Number:
PC0206
pCPA Engagement Letter Issued:
Negotiation Process Concluded: